Article
Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis.
Clinics in chest medicine - 1 Dec 2022
Guimbellot Jennifer S, Nichols David P, Brewington John J
Abstract excerpt
As routine care in cystic fibrosis (CF) becomes increasingly personalized, new opportunities to further focus care on the individual have emerged. These opportunities are increasingly filled through research in tools aiding drug selection, drug monitoring and titration, disease-relevant biomarkers, and evaluation of therapeutic benefits. Herein, we will discuss such research tools presently being translated into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
